Ying Ann Chiao1, Akash Deep Chakraborty1,2, Christine M Light2, Rong Tian3, Junichi Sadoshima, Xiaojian Shi4, Haiwei Gu4, Chi Fung Lee2,5. 1. Aging and Metabolism Research Program (Y.A.C., A.D.C.), Oklahoma Medical Research Foundation, Oklahoma City. 2. Cardiovascular Biology Research Program (A.D.C., C.M.L., C.F.L.), Oklahoma Medical Research Foundation, Oklahoma City. 3. Mitochondria and Metabolism Center, University of Washington, Seattle (R.T.). Department of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Newark (J.S.). 4. Arizona Metabolomics Laboratory, College of Health Solutions, Arizona State University, Scottsdale (X.S., H.G.). 5. Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City (C.F.L.).
Abstract
BACKGROUND: Diabetes is a risk factor for heart failure and promotes cardiac dysfunction. Diabetic tissues are associated with nicotinamide adenine dinucleotide (NAD+) redox imbalance; however, the hypothesis that NAD+ redox imbalance causes diabetic cardiomyopathy has not been tested. This investigation used mouse models with altered NAD+ redox balance to test this hypothesis. METHODS: Diabetic stress was induced in mice by streptozotocin. Cardiac function was measured by echocardiography. Heart and plasma samples were collected for biochemical, histological, and molecular analyses. Two mouse models with altered NAD+ redox states (1, Ndufs4 [NADH:ubiquinone oxidoreductase subunit S4] knockout, cKO, and 2, NAMPT [nicotinamide phosphoribosyltranferase] transgenic mice, NMAPT) were used. RESULTS: Diabetic stress caused cardiac dysfunction and lowered NAD+/NADH ratio (oxidized/reduced ratio of nicotinamide adenine dinucleotide) in wild-type mice. Mice with lowered cardiac NAD+/NADH ratio without baseline dysfunction, cKO mice, were challenged with chronic diabetic stress. NAD+ redox imbalance in cKO hearts exacerbated systolic (fractional shortening: 27.6% versus 36.9% at 4 weeks, male cohort P<0.05), and diastolic dysfunction (early-to-late ratio of peak diastolic velocity: 0.99 versus 1.20, P<0.05) of diabetic mice in both sexes. Collagen levels and transcripts of fibrosis and extracellular matrix-dependent pathways did not show changes in diabetic cKO hearts, suggesting that the exacerbated cardiac dysfunction was due to cardiomyocyte dysfunction. NAD+ redox imbalance promoted superoxide dismutase 2 acetylation, protein oxidation, troponin I S150 phosphorylation, and impaired energetics in diabetic cKO hearts. Importantly, elevation of cardiac NAD+ levels by NAMPT normalized NAD+ redox balance, alleviated cardiac dysfunction (fractional shortening: 40.2% versus 24.8% in cKO:NAMPT versus cKO, P<0.05; early-to-late ratio of peak diastolic velocity: 1.32 versus 1.04, P<0.05), and reversed pathogenic mechanisms in diabetic mice. CONCLUSIONS: Our results show that NAD+ redox imbalance to regulate acetylation and phosphorylation is a critical mediator of the progression of diabetic cardiomyopathy and suggest the therapeutic potential for diabetic cardiomyopathy by harnessing NAD+ metabolism.
BACKGROUND: Diabetes is a risk factor for heart failure and promotes cardiac dysfunction. Diabetic tissues are associated with nicotinamide adenine dinucleotide (NAD+) redox imbalance; however, the hypothesis that NAD+ redox imbalance causes diabetic cardiomyopathy has not been tested. This investigation used mouse models with altered NAD+ redox balance to test this hypothesis. METHODS: Diabetic stress was induced in mice by streptozotocin. Cardiac function was measured by echocardiography. Heart and plasma samples were collected for biochemical, histological, and molecular analyses. Two mouse models with altered NAD+ redox states (1, Ndufs4 [NADH:ubiquinone oxidoreductase subunit S4] knockout, cKO, and 2, NAMPT [nicotinamide phosphoribosyltranferase] transgenic mice, NMAPT) were used. RESULTS: Diabetic stress caused cardiac dysfunction and lowered NAD+/NADH ratio (oxidized/reduced ratio of nicotinamide adenine dinucleotide) in wild-type mice. Mice with lowered cardiac NAD+/NADH ratio without baseline dysfunction, cKO mice, were challenged with chronic diabetic stress. NAD+ redox imbalance in cKO hearts exacerbated systolic (fractional shortening: 27.6% versus 36.9% at 4 weeks, male cohort P<0.05), and diastolic dysfunction (early-to-late ratio of peak diastolic velocity: 0.99 versus 1.20, P<0.05) of diabetic mice in both sexes. Collagen levels and transcripts of fibrosis and extracellular matrix-dependent pathways did not show changes in diabetic cKO hearts, suggesting that the exacerbated cardiac dysfunction was due to cardiomyocyte dysfunction. NAD+ redox imbalance promoted superoxide dismutase 2 acetylation, protein oxidation, troponin I S150 phosphorylation, and impaired energetics in diabetic cKO hearts. Importantly, elevation of cardiac NAD+ levels by NAMPT normalized NAD+ redox balance, alleviated cardiac dysfunction (fractional shortening: 40.2% versus 24.8% in cKO:NAMPT versus cKO, P<0.05; early-to-late ratio of peak diastolic velocity: 1.32 versus 1.04, P<0.05), and reversed pathogenic mechanisms in diabetic mice. CONCLUSIONS: Our results show that NAD+ redox imbalance to regulate acetylation and phosphorylation is a critical mediator of the progression of diabetic cardiomyopathy and suggest the therapeutic potential for diabetic cardiomyopathy by harnessing NAD+ metabolism.
Authors: Patrick A Carroll; Daniel Diolaiti; Lisa McFerrin; Haiwei Gu; Danijel Djukovic; Jianhai Du; Pei Feng Cheng; Sarah Anderson; Michelle Ulrich; James B Hurley; Daniel Raftery; Donald E Ayer; Robert N Eisenman Journal: Cancer Cell Date: 2015-01-29 Impact factor: 31.743
Authors: Kathryn F Mills; Shohei Yoshida; Liana R Stein; Alessia Grozio; Shunsuke Kubota; Yo Sasaki; Philip Redpath; Marie E Migaud; Rajendra S Apte; Koji Uchida; Jun Yoshino; Shin-Ichiro Imai Journal: Cell Metab Date: 2016-10-27 Impact factor: 27.287
Authors: Nicolas Diguet; Samuel A J Trammell; Cynthia Tannous; Robin Deloux; Jérôme Piquereau; Nathalie Mougenot; Anne Gouge; Mélanie Gressette; Boris Manoury; Jocelyne Blanc; Marie Breton; Jean-François Decaux; Gareth G Lavery; István Baczkó; Joffrey Zoll; Anne Garnier; Zhenlin Li; Charles Brenner; Mathias Mericskay Journal: Circulation Date: 2017-12-07 Impact factor: 29.690
Authors: Georgios Karamanlidis; Chi Fung Lee; Lorena Garcia-Menendez; Stephen C Kolwicz; Wichit Suthammarak; Guohua Gong; Margaret M Sedensky; Philip G Morgan; Wang Wang; Rong Tian Journal: Cell Metab Date: 2013-08-06 Impact factor: 27.287
Authors: Ying Ann Chiao; Stephen C Kolwicz; Nathan Basisty; Arni Gagnidze; Julia Zhang; Haiwei Gu; Danijel Djukovic; Richard P Beyer; Daniel Raftery; Michael MacCoss; Rong Tian; Peter S Rabinovitch Journal: Aging (Albany NY) Date: 2016-02 Impact factor: 5.682
Authors: Jessica M Berthiaume; Chia-Heng Hsiung; Alison B Austin; Sean P McBrayer; Mikayla M Depuydt; Margaret P Chandler; Masaru Miyagi; Mariana G Rosca Journal: Mol Cell Biochem Date: 2017-03-16 Impact factor: 3.396
Authors: Russell P Goodman; Andrew L Markhard; Hardik Shah; Rohit Sharma; Owen S Skinner; Clary B Clish; Amy Deik; Anupam Patgiri; Yu-Han H Hsu; Ricard Masia; Hye Lim Noh; Sujin Suk; Olga Goldberger; Joel N Hirschhorn; Gary Yellen; Jason K Kim; Vamsi K Mootha Journal: Nature Date: 2020-05-27 Impact factor: 49.962
Authors: Hina Lateef Nizami; Keaton E Minor; Ying Ann Chiao; Christine M Light; Chi Fung Lee Journal: Am J Physiol Heart Circ Physiol Date: 2022-09-02 Impact factor: 5.125
Authors: M-K Torp; T Ranheim; C Schjalm; M Hjorth; C M Heiestad; K T Dalen; P H Nilsson; T E Mollnes; S E Pischke; E Lien; J Vaage; A Yndestad; K-O Stensløkken Journal: Front Immunol Date: 2022-04-01 Impact factor: 8.786
Authors: Julia C Stokes; Rebecca L Bornstein; Katerina James; Kyung Yeon Park; Kira A Spencer; Katie Vo; John C Snell; Brittany M Johnson; Philip G Morgan; Margaret M Sedensky; Nathan A Baertsch; Simon C Johnson Journal: JCI Insight Date: 2022-03-08